EUVIMEDEUVIMED entdecken
Crossref

Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity

Rie Matsushima-Nishiwaki, Shota Kamoi, Osamu Kozawa

Cell Biochemistry and Function · 2023-10 · 41 (7) · 814-822

DOI: 10.1002/cbf.3831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, online erschienen am 25.07.2023. Verfasst von Rie Matsushima-Nishiwaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Graduate School of Medicine, Gifu University, Gifu, Gifu Prefecture, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duloxetine, a selective reuptake inhibitor for serotonin and norepinephrine, is a medication widely used for major depression. Currently, duloxetine is also recommended for pain related to chemotherapy‐induced peripheral neuropathy or cancer. Previously, we showed that transforming growth factor‐α (TGF‐α) induces the migration of human hepatocellular carcinoma (HCC)‐derived HuH7 cells through the activation of c‐Jun N‐terminal kinase (JNK), p38 mitogen‐activated protein kinase (MAPK) and AKT. In the present study, we investigate whether duloxetine affects cell migration and its mechanism. Duloxetine significantly enhanced the TGF‐α‐induced migration of HuH7 cells. Fluvoxamine and sertraline, specific inhibitors of serotonin reuptake, also upregulated the TGF‐α‐induced cell migration. On the contrary, reboxetine, a specific norepinephrine reuptake inhibitor, failed to affect cell migration. Duloxetine significantly amplified the TGF‐α‐stimulated phosphorylation of JNK, but not p38 MAPK and AKT. In addition, fluvoxamine and sertraline, but not reboxetine, enhanced the phosphorylation of JNK. SP600125, a JNK inhibitor, suppressed the enhancement by duloxetine, fluvoxamine, or sertraline of TGF‐α‐induced migration of HuH7 cells. Taken together, our results strongly suggest that duloxetine strengthens the TGF‐α‐induced activation of JNK via inhibition of serotonin reuptake in HCC cells, leading to the enhancement of cell migration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansDuloxetine HydrochlorideFluvoxamineJNK Mitogen-Activated Protein KinasesNorepinephrinep38 Mitogen-Activated Protein KinasesPhosphorylationProto-Oncogene Proteins c-aktSerotoninSertralineTransforming Growth Factor alphaUp-Regulation

Stichwörter der Autor:innen

HCCJNKTGF-αduloxetinemigrationserotonin transporter

Substanzen

Duloxetine HydrochlorideFluvoxamineJNK Mitogen-Activated Protein KinasesNorepinephrinep38 Mitogen-Activated Protein KinasesProto-Oncogene Proteins c-aktSerotoninSertralineTransforming Growth Factor alpha

Autor:innen und Institutionen

  • Department of Pharmacology, Graduate School of Medicine, Gifu University, Gifu, Gifu Prefecture, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Matsushima-Nishiwaki, R., Kamoi, S., & Kozawa, O. (2023). Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity. Cell Biochemistry and Function, 41(7), 814-822. https://doi.org/10.1002/cbf.3831

Vancouver

Matsushima-Nishiwaki R, Kamoi S, Kozawa O. Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity. Cell Biochemistry and Function. 2023;41(7):814-822. doi:10.1002/cbf.3831

BibTeX
@article{MatsushimaNishiwaki2023,
  author = {Matsushima-Nishiwaki, Rie and Kamoi, Shota and Kozawa, Osamu},
  title = {Upregulation by duloxetine of the transforming growth factor‐α‐induced migration of hepatocellular carcinoma cells via enhancement of the c‐ Jun N‐terminal kinase activity},
  journal = {Cell Biochemistry and Function},
  year = {2023},
  volume = {41},
  number = {7},
  pages = {814--822},
  doi = {10.1002/cbf.3831}
}
Kostenlos starten →